Latest Sprint Bioscience News & Updates

See the latest news and media coverage for Sprint Bioscience. We track all announcements, press releases, and industry mentions in real time, all in one place.

Sprint Bioscience

Pharmaceutical company developing oncology drug candidates

sprintbioscience.com

Headquarters: Huddinge, Sweden
Founded year: 2009
Company type: Public company
Number of employees: 40–50
Industry: Pharmaceuticals

Last updated Today

Latest news about Sprint Bioscience

In short: Sprint Bioscience sold its TREX1 program to Gilead Sciences for up to $414 million and partnered with Lilly TuneLab for AI development.

Company announcements

July 23 Sprint Bioscience

Sprint Bioscience has entered into an agreement with Lilly TuneLab

The agreement provides access to AI models to accelerate drug development and strengthen preclinical programs.

May 13 Sprint Bioscience

Sprint Bioscience held its annual general meeting on May 13, 2026

Board re-elected, new election of Andreas Lindenhierta, authorization for issue resolved.

May 13 Sprint Bioscience

Sprint Bioscience publishes interim report for the first quarter of 2026

Net sales amounted to SEK 0 million and operating result to SEK -14.3 million, as well as positive preclinical results in VRK1 and NNMT.

April 15 Sprint Bioscience

Sprint Bioscience publishes the annual report for 2025

The annual report for the 2025 fiscal year is available on the company's website. Link to the report is in the message.

Media coverage

August 26 Finanzen.ch

Sprint Bioscience AB opened the books for the past quarter

Sprint Bioscience AB opened the books for the quarter ending on June 30, 2026 on August 26, 2026. The EPS was -0.15 SEK. A year earlier, it was...

July 22 FinanzNachrichten.de

Sprint Bioscience AB: Sprint Bioscience announces agreement with Lilly TuneLab to accelerate drug development

Sprint Bioscience AB (publ) today announced that it has entered into an agreement with Lilly TuneLab, a collaborative AI-driven drug discovery platform created by Eli...

April 16 FinanzNachrichten.de

Sprint Bioscience AB: Sprint Bioscience completes strategic STK25 evaluation; continued focus on the primary indication

Sprint Bioscience AB (publ) today announces the conclusion of a targeted evaluation of the STK25 program, conducted in partnership with the Experimental Drug Development Centre...

March 17 Dagens industri

Sprint Bioscience: Positive results in brain cancer study

Sprint Bioscience announces what the research company describes as positive results from a preclinical proof-of-concept study regarding...

Never miss news about Sprint Bioscience

Track Sprint Bioscience and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Sprint Bioscience competitors & trending companies

Browse news for competitors to Sprint Bioscience and other trending companies.